CJC-1295 DAC

Investigational Long-Acting GHRH Analogue

Overview

CJC-1295 DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH) studied for prolonged activity through modification with a Drug Affinity Complex (DAC).

Current research examines GHRH receptor signaling, growth hormone and IGF-1–related pathways, endocrine signaling, pharmacokinetic behavior, and associated physiological mechanisms.

Research Focus

  • GHRH receptor signaling

  • Growth hormone–related pathways

  • GH / IGF-1 axis research

  • Endocrine signaling mechanisms

  • Peptide pharmacokinetic research

Product Specifications

Form: Lyophilized peptide

In-Stock Strengths: 5 mg

Special-Order Strengths: 10 mg

Special Orders

Additional strengths may be available by special order. Availability, pricing, and lead times are subject to confirmation.

Storage

Store refrigerated at 2–8°C, unless otherwise specified.

Research Use Only

For laboratory and research applications only. Not intended for human or veterinary use, consumption, diagnosis, treatment, or clinical application.

Toronto-Based • Expanding Canada-Wide
Serving Vancouver & Beyond

Contact
437-318-5219
info@izabiosciences.com

© 2026 IZA Biosciences. All rights reserved.

For Research Use Only. Products offered by IZA Biosciences are intended exclusively for laboratory and research purposes. They are not intended for human or veterinary use, consumption, diagnosis, treatment, cure, or prevention of any disease. Purchasers are responsible for ensuring that all products are handled and used in accordance with applicable laws, regulations, and institutional requirements.